Theo Verheij

Dr. Theo Verheij


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2013 in Implementation Science
Verified
Journal Article
Open access
PDF file
LYLucy Yardley
Lucy Yardley
EDElaine Douglas
Elaine Douglas
SASibyl Anthierens
Sibyl Anthierens
STSarah Tonkin-Crine
Sarah Tonkin-Crine
GOGilly O’rEilly
Gilly O’rEilly
Paul LittlePaul Little
Paul Little
To reduce the spread of antibiotic resistance, there is a pressing need for worldwide implementation of effective interventions to promote more prudent prescribing of antibiotics for acute LRTI. This study is a process analysis of the GRACE/INTRO trial of a multifactorial intervention that reduced antibiotic prescribing for acute LRTI in six European countries. The aim was to understand how the interventions were implemented and to examine effects of the interventions on general practitioners’ (GPs’) and patients’ attitudes. GPs were cluster randomised to one of three intervention groups or a control group. The intervention groups received web-based training in either use of the C-reactive protein (CRP) test, communication skills and use of a patient booklet, or training in both. GP attitudes were measured before and after the intervention using constructs from the Theory of Planned Behaviour and a Website Satisfaction Questionnaire. Effects of the interventions on patients were assessed by a post-intervention questionnaire assessing patient enablement, satisfaction with the consultation, and beliefs about the risks and need for antibiotics. GPs in all countries and intervention groups had very positive perceptions of the intervention and the web-based training, and felt that taking part had helped them to reduce prescribing. All GPs perceived reducing prescribing as more important and less risky following the intervention, and GPs in the communication groups reported increased confidence to reduce prescribing. Patients in the communication groups who received the booklet reported the highest levels of enablement and satisfaction and had greater awareness that antibiotics could be unnecessary and harmful. Our findings suggest that the interventions should be broadly acceptable to both GPs and patients, as well as feasible to roll out more widely across Europe. There are also some indications that they could help to engender changes in GP and patient attitudes that will be helpful in the longer-term, such as increased awareness of the potential disadvantages of antibiotics and increased confidence to manage LRTI without them. Given the positive effects of the booklet on patient beliefs and attitudes, it seems logical to extend the use of the patient booklet to all patients.

11 October 2012 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
SASibyl Anthierens
Sibyl Anthierens
STSarah Tonkin-Crine
Sarah Tonkin-Crine
EDElaine Douglas
Elaine Douglas
PFPatricia Fernandez-Vandellos
Patricia Fernandez-Vandellos
JKJaroslaw Krawczyk
Jaroslaw Krawczyk
TTthe GRACE INTRO study team
the GRACE INTRO study team
Background: Interventions to promote prudent antibiotic prescribing by general practitioners (GPs) have often only been developed for use in one country. We aimed to develop an intervention which would be appropriate to implement in multiple European countries in order to offer greater benefit to practice whilst using fewer resources. The INTRO (INternet TRaining for antibiOtic use) intervention needed to deliver training to GPs in the use of C-Reactive Protein (CRP) near patient tests to help diagnose acute cough and in communication skills to help explain prescribing decisions to patients. We explored GPs’ views on the initial version of INTRO to test acceptability and potentially increase applicability for use in multiple countries before the start of a randomised trial.Method: 30 GPs from five countries (Belgium, England, the Netherlands, Poland and Spain), were interviewed using a “think aloud” approach. GPs were asked to work through the intervention and discuss their views on the content and format in relation to following the intervention in their own practice. GPs viewed the same intervention but versions were created in five languages. Data were coded using thematic analysis.Results: GPs in all five countries reported the view that the intervention addressed an important topic, was broadly acceptable and feasible to use, and would be a useful tool to help improve clinical practice. However, GPs in the different countries identified aspects of the intervention that did not reflect their national culture or healthcare system. These included perceived differences in communication style used in the consultation, consultation length and the stage of illness at which patient typically presented.Conclusion: An online intervention to support evidence-based use of antibiotics is acceptable and feasible to implement amongst GPs in multiple countries. However, tailoring of the intervention to suit national contexts was necessary by adding local information and placing more emphasis on the fact that GPs could select the communication skills they wished to use in practice. Using think aloud methods to complement the development of interventions is a powerful method to identify regional contextual barriers to intervention implementation.

1 November 2011 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
DZDorien Lm Zwart
Dorien Lm Zwart
MLMaaike Langelaan
Maaike Langelaan
RVRosalinde C van de Vooren
Rosalinde C van de Vooren
MKMarijke M Kuyvenhoven
Marijke M Kuyvenhoven
CKCor J Kalkman
Cor J Kalkman
Cordula WagnerCordula Wagner
Cordula Wagner
A supportive patient safety culture is considered to be an essential condition for improving patient safety. Assessing the current safety culture in general practice may be a first step to target improvements. To that end, we studied internal consistency and construct validity of a safety culture questionnaire for general practice (SCOPE) which was derived from a comparable questionnaire for hospitals (Dutch-HSOPS).

7 June 2017 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
TSTanly Su
Tanly Su
BBBerna D. L. Broekhuizen
Berna D. L. Broekhuizen
TVTheo Verheij
Theo Verheij
HRHeike Rockmann
Heike Rockmann
Suspected penicillin allergy (Pen-A) is often not verified by diagnostic testing. In third line penicillin allergy labels were associated with prescription of broad spectrum antibiotics, hospital stay duration and readmission. Assess the impact of Pen-A labels on antibiotic and health care use in primary care. A retrospective cohort study was conducted in primary care in the Utrecht area, the Netherlands. All patients registered with a penicillin allergy on 31 December 2013 were selected from the General Practitioner Network database. Each patient with a Pen-A label was matched for age, gender, follow-up period with three patients without Pen-A label. Risk (OR) of receiving a reserve and second choice antibiotic, number and type of antibiotics prescribed during follow-up and number of GP contacts were compared between the two cohorts. Of 196,440 patients, 1254 patients (0.6%) with a Pen-A label were identified and matched with 3756 patients without Pen-A label. Pen-A labels resulted in higher risk of receiving ≥1 antibiotic prescription per year (OR 2.56, 95% CI 2.05–3.20), ≥1 s choice antibiotic prescription per year (OR 2.21 95% CI 1.11–4.40), and ≥4 GP contacts per year (OR 1.71 95% CI 1.46–2.00). The chance of receiving tetracyclins (OR 2.24, 95% CI 1.29–3.89), macrolides/lincosamides/streptogamins (OR 8.69, 95% CI 4.26–17.73) and quinolones (OR 2.59, 95% CI 1.22–5.48) was higher in Pen-A patients. In primary health care Pen-A labels are associated with increased antibiotic use, including second choice antibiotics, and more health care use.

17 December 2021 in BJGP Open
Verified
Journal Article
Open access
PDF file
AVAlike Van Der Velden
Alike Van Der Velden
APAlma C van de Pol
Alma C van de Pol
EBEmily Bongard
Emily Bongard
DCDaniela Cianci
Daniela Cianci
RARune Aabenhus
Rune Aabenhus
CBChristopher Butler
Christopher Butler
Background: Between-country differences have been described in antibiotic prescribing for respiratory tract infection (RTI) in primary care, but not yet for diagnostic testing procedures and prescribing confidence.Aim: To describe between-country differences in RTI management, particularly diagnostic testing and antibiotic prescribing, and investigate which factors relate to antibiotic prescribing and GPs’ prescribing confidence.Design & setting: Prospective audit in 18 European countries.Method: An audit of GP-registered patient, clinical, and management characteristics for patients presenting with sore throat and/or lower RTI (n= 4982), and GPs' confidence in their antibiotic prescribing decision. Factors related to antibiotic prescribing and confidence were analysed using multi-level logistic regression.Results: Antibiotic prescribing proportions varied considerably: 40% in six countries. There was also considerable variation in point-of-care (POC) testing (0% in Croatia, Moldova, and Romania, and >65% in Denmark and Norway, mainly for C-reactive protein [CRP] and group A streptococcal [strep A] infection), and in laboratory or hospital-based testing (30% in Croatia, Georgia, Greece, and Moldova, mainly chest X-ray and white blood cell counting). Antibiotic prescribing was related to illness severity, comorbidity, age, fever, and country, but not to having performed a POC test. In nearly 90% of consultations, GPs were confident in their antibiotic prescribing decision.Conclusion: Despite high confidence in decisions about antibiotic prescribing, there is considerable variation in the primary care of RTI in European countries, with GPs prescribing antibiotics overall more often than is considered appropriate. POC testing may enhance the quality of antibiotic prescribing decisions if it can safely reverse decisions confidently made on clinical grounds alone to prescribe antibiotics.

19 May 2011 in Implementation Science
Verified
Journal Article
Open access
PDF file
IAIngrid Looijmans-Van Den Akker
Ingrid Looijmans-Van Den Akker
MHMarlies E Hulscher
Marlies E Hulscher
TVTheo Verheij
Theo Verheij
JRJosien Riphagen-Dalhuisen
Josien Riphagen-Dalhuisen
JDJohannes JM van Delden
Johannes JM van Delden
EHEelko Hak
Eelko Hak
Background: Apart from direct protection and reduced productivity loss during epidemics, the main reason to immunize healthcare workers (HCWs) against influenza is to provide indirect protection of frail patients through reduced transmission in healthcare settings. Because the vaccine uptake among HCWs remains far below the health objectives, systematic programs are needed to take full advantage of such vaccination. In an earlier report, we showed a mean 9% increase of vaccine uptake among HCWs in nursing homes that implemented a systematic program compared with control homes, with higher rates in those homes that implemented more program elements. Here, we report in detail the process of the development of the implementation program to enable researchers and practitioners to develop intervention programs tailored to their setting. Methods: We applied the intervention mapping (IM) method to develop a theory- and evidence-based intervention program to change vaccination behaviour among HCWs in nursing homes. Results: After a comprehensive needs assessment, we were able to specify proximal program objectives and selected methods and strategies for inducing behavioural change. By consensus, we decided on planning of three main program components, i.e., an outreach visit to all nursing homes, plenary information meetings, and the appointment of a program coordinator -- preferably a physician -- in each home. Finally, we planned program adoption, implementation, and evaluation. Conclusion: The IM methodology resulted in a systematic, comprehensive, and transparent procedure of program development. A potentially effective intervention program to change influenza vaccination behaviour among HCWs was developed, and its impact was assessed in a clustered randomised controlled trial.